BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6981637)

  • 1. Monoclonal antibody (B27M2) subdividing HLA-B27.
    Grumet FC; Fendly BM; Fish L; Foung S; Engleman EG
    Hum Immunol; 1982 Aug; 5(1):61-72. PubMed ID: 6981637
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibodies to HLA-B27.
    Grumet FC
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):110-8. PubMed ID: 6360285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular variants of the HLA-B27 antigen in healthy individuals and patients with spondylarthropathies.
    Turek PJ; Grumet FC; Engleman EG
    Immunol Rev; 1985 Aug; 86():71-91. PubMed ID: 2412952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of HLA-B27 antigen with monoclonal antibodies.
    Engleman EG; Calin A; Grumet FC
    J Rheumatol Suppl; 1983 Nov; 10():59-61. PubMed ID: 6420568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemical variants of HLA-B27.
    Kaneoka H; Engleman EG; Grumet FC
    J Immunol; 1983 Mar; 130(3):1288-92. PubMed ID: 6600481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cytolytic human T lymphocyte clone differentially recognizing HLA-B27 subtypes.
    Miyachi Y; Wee SL; Chen LK; Grumet FC; Bowman RJ; Taurog JD
    Hum Immunol; 1984 Aug; 10(4):237-49. PubMed ID: 6206036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spondyloarthritis, uveitis, HLA-B27 and Klebsiella.
    Ebringer A; Baines M; Ptaszynska T
    Immunol Rev; 1985 Aug; 86():101-16. PubMed ID: 2412951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A common epitope between HLA-B27, -B13 and -B37 alloantigens defined by a monoclonal antibody.
    Bourel D; Fauchet R; Dejour G; Bouhallier O; Merdrignac G; Chales G; Genetet B
    Tissue Antigens; 1987 Sep; 30(3):97-103. PubMed ID: 2447679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-B7/B27 constructs: a tool to understand the molecular mimicry hypothesis between HLA-B27 and gram-negative bacterial antigens in ankylosing spondylitis.
    Toubert A; Sire J; Sodoyer R; Amor B; Jordan BR
    Br J Rheumatol; 1988; 27 Suppl 2():19-22. PubMed ID: 3261187
    [No Abstract]   [Full Text] [Related]  

  • 10. Description of a mouse monoclonal anti-HLA-B27 antibody HLA-ABC-m3.
    Trapani JA; Vaughan HA; Sparrow RL; Tait BD; McKenzie IF
    Hum Immunol; 1983 Aug; 7(4):205-16. PubMed ID: 6604046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-B27 associated cross-reactive marker on the cells of New Zealand patients with ankylosing spondylitis.
    McGuigan LE; Geczy AF; Prendergast JK; Edmonds JP; Hart HH; Bashir HV
    Ann Rheum Dis; 1986 Feb; 45(2):144-8. PubMed ID: 3484937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteric bacteria and HLA-B27 associated cell surface modification in patients with seronegative spondarthritis.
    Edmonds J; Geczy AF; Sullivan JS; Prendergast JK; Upfold LI; Bashir HV
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):75-82. PubMed ID: 6606476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of HLA antigens A and B and their cross reactions in B27-negative ankylosing spondylarthritis].
    Dreyfus P; Geay D; Cambon H; Daupleix D
    Rev Rhum Mal Osteoartic; 1984 May; 51(5):269-72. PubMed ID: 6610919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An antiserum to a disease-associated factor from the cells of an HLA-B27 positive patient with ankylosing spondylitis specifically recognizes an HLA-B27 associated determinant.
    Sullivan JS; Geczy AF
    Arthritis Rheum; 1987 Apr; 30(4):439-42. PubMed ID: 2437933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydial antibody crossreactivity with peripheral blood mononuclear cells of patients with ankylosing spondylitis: the role of HLA B27.
    Wakefield D; Easter J; Robinson P; Graham D; Penny R
    Clin Exp Immunol; 1986 Jan; 63(1):49-57. PubMed ID: 3485486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-B27: speculations on the nature of its involvement in ankylosing spondylitis.
    Upfold LI; Sullivan JS; Prendergast JK; Geczy AF
    Prog Allergy; 1985; 36():177-89. PubMed ID: 3881781
    [No Abstract]   [Full Text] [Related]  

  • 17. Klebsiella 'modifying factor': binding studies with HLA-B27+ and B27- lymphocytes.
    Trapani JA; McKenzie IF
    Ann Rheum Dis; 1985 Mar; 44(3):169-75. PubMed ID: 2579614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ankylosing spondylitis, HLA-B27, and klebsiella: cross reactivity and antibody studies.
    Ebringer A; Ghuloom M
    Ann Rheum Dis; 1986 Aug; 45(8):703-4. PubMed ID: 3488716
    [No Abstract]   [Full Text] [Related]  

  • 19. Cross-reactivity of anti-Klebsiella K43 antiserum and lymphocytes from HLA-B27-positive patients with ankylosing spondylitis.
    Struthers GR
    Lancet; 1985 Mar; 1(8431):764. PubMed ID: 2858037
    [No Abstract]   [Full Text] [Related]  

  • 20. Measurement of HLA class I expression in ankylosing spondylitis.
    Creamer P; Edmonds J; Sullivan J; Matthews S
    Ann Rheum Dis; 1992 Oct; 51(10):1138-42. PubMed ID: 1444627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.